Abstracts tagged "patient participation and rheumatoid arthritis (RA)"

Abstract Number: 1409 • 2018 ACR/ARHP Annual Meeting
Empowerment in Hispanic Rheumatoid Arthritis Patients: A Validation Study
Emmanuel Ruiz-Medrano¹, Irazú Contreras-Yáñez², Luz del Carmen Hernández³ and Virginia Pascual-Ramos⁴, ¹Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ²Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ³UCB Pharmaceutical, Mexico City, Mexico, ⁴Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Background/Purpose: The World Health Organization describes empowerment in health promotion work as a process in which the person receives more control over decisions and actions…
Abstract Number: 1241 • 2017 ACR/ARHP Annual Meeting
Understanding Differences in Patient Definitions of RA Flares Using Omeract Core Domains
Gabriela L. Maica¹, Michelle Frits², Christine Iannaccone³, Taysir G. Mahmoud⁴, Clifton O. Bingham III⁵, Vivian P. Bykerk⁶, Michael Weinblatt⁷ and Nancy A. Shadick⁸, ¹Department of Rheumatology, Allergy, and Immunology, Brigham and Women's Hospital, Boston, MA, ²Brigham and Women's Hospital, Boston, MA, ³Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁴Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁵Rheumatology, Johns Hopkins University, Baltimore, MD, ⁶2-005, Mt Sinai Hospital, Toronto, ON, Canada, ⁷Rheumatology, Immunology and Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁸Rheumatology Immunology & Allergy, Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Flare is an important, distinct feature of RA, often rendering patients immobile and contributing to a poor quality of life. Recently, there has been…
Abstract Number: 88 • 2016 ACR/ARHP Annual Meeting
Patient-Clinician Co-Participation in Design of an App for RA Management Via Telehealth Yields an App with High Usability and Acceptance
Rebecca Grainger^1,2, Tobias Langlotz³, Hermaleigh Townsley⁴ and William Taylor^1,5, ¹University of Otago Wellington, Wellington, New Zealand, ²Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Lower Hutt, New Zealand, ³Department of Information Science, University of Otago, Dunedin, New Zealand, ⁴Department of Medicine, University of Otago Wellington, Wellington, New Zealand, ⁵Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Wellington, New Zealand
Background/Purpose: Traditional management of rheumatoid arthritis (RA) is by rheumatologist review 3 to 6 monthly. This is not sustainable in many healthcare systems as demand…
Abstract Number: 2483 • 2016 ACR/ARHP Annual Meeting
Results of a Pilot Study of a Tailored Symptom Assessment Tool to Enhance Patient-Centered Care in Rheumatoid Arthritis: Choice RA
Jennifer Barton¹, Gina Evans-Young², Laura Trupin³, Allison Schue¹, Cornelia Ruland⁴ and Edward H. Yelin³, ¹VA Portland Health Care System, Portland, OR, ²Rheumatology, UCSF, San Francisco, CA, ³Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ⁴Oslo University Hospital, Oslo, Norway
Background/Purpose: Methods: Results: Conclusion:

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].